Dysregulation of DNA repair pathways in a transforming growth factor alpha/c-myc transgenic mouse model of

Koji Hironaka1, Valentina M Factor, Diego F Calvisi

  • 1Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

Insights

Oxidative stress accelerates liver cancer in TGFalpha/c-myc mice due to impaired DNA repair. DNA repair gene expression is altered, and response to further damage is reduced, contributing to cancer progression.

Area of Science:

  • Hepatocarcinogenesis research
  • Molecular biology
  • Genetics

Background:

  • Oxidative DNA damage and genetic instability are implicated in TGFalpha/c-myc-associated hepatocarcinogenesis.
  • TGFalpha/c-myc mice exhibit more aggressive liver cancer than c-myc single-transgenic mice.
  • Investigating DNA repair defects is crucial for understanding accelerated liver cancer in TGFalpha/c-myc models.

Purpose of the Study:

  • To determine if defects in DNA repair pathways contribute to the acceleration of liver cancer in TGFalpha/c-myc mice.
  • To compare the basal expression levels of DNA repair genes in transgenic and wild-type mouse livers.
  • To assess the response of DNA repair pathways to oxidative stress induction.

Main Methods:

  • Utilized cDNA expression arrays with 140 known genes and multiplex RT-PCR.
  • Compared DNA repair gene expression in 10-week-old TGFalpha/c-myc, c-myc, and wild-type mouse livers.
  • Administered Wy-14,643 (a peroxisome proliferator) to induce oxidative stress.

Main Results:

  • Constitutive up-regulation of base excision, nucleotide excision, and DNA strand break repair genes was observed in both TGFalpha/c-myc and c-myc livers.
  • Wy-14,643 failed to further increase DNA repair enzyme expression in TGFalpha/c-myc livers, unlike in c-myc or wild-type livers.
  • Decreased expression of Ku80, PMS2, and ATM in TGFalpha/c-myc livers suggests impaired DNA repair pathway activation under oxidative stress.

Conclusions:

  • DNA damage response is attenuated in TGFalpha/c-myc mice.
  • This attenuation likely contributes to the acceleration of liver cancer in this model.
  • Defects in DNA repair pathways play a significant role in TGFalpha/c-myc-associated hepatocarcinogenesis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...